Identifying enhancer-driven subtype-specific prognostic markers in breast cancer based on multi-omics data.
Zhao H, Zhang S, Yin X, Zhang C, Wang L, Liu K, Xu H, Liu W, Bo L, Lin S, Feng K, Lin L, Fei M, Ning S, Wang L.
Zhao H, et al. Among authors: zhang s, zhang c.
Front Immunol. 2022 Oct 11;13:990143. doi: 10.3389/fimmu.2022.990143. eCollection 2022.
Front Immunol. 2022.
PMID: 36304471
Free PMC article.